HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thymidine phosphorylase (platelet-derived endothelial cell growth factor) as a target for capecitabine: from biology to the bedside.

Abstract
Thymidine phosphorylase (TP), also known as platelet derived endothelial cell growth factor (PD-ECGF), is an enzyme involved in thymidine synthesis and degradation and exerts an angiogenic activity, whereas N4 pentyloxy-carbonyl- 5'-deoxy-5-fluorocytidine, commonly called capecitabine (CAP), is a TP-activated oral fluorpyrimidine, which generates 5-fluorouracil (5-FU) within tumours. In addition to its classic antitumour activity, recent studies suggest that CAP may act as an antiangiogenetic molecule. Assessment of tumour microvessel density as expressed by endothelial cell TP positivity may identify the most vascularized and hence CAP-sensitive tumours. This review summarizes: (i) the biochemical and tissue expression of TP; (ii) the pharmacological profile of CAP as an anti-cancer compound and the central role of TP in its activation; (iii) the potential antiangiogenetic role of TP-activated CAP in tumours.
AuthorsGirolamo Ranieri, Aldo Maria Roccaro, Angelo Vacca, Domenico Ribatti
JournalRecent patents on anti-cancer drug discovery (Recent Pat Anticancer Drug Discov) Vol. 1 Issue 2 Pg. 171-83 (Jun 2006) ISSN: 1574-8928 [Print] United Arab Emirates
PMID18221035 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Angiogenesis Inhibitors
  • Antimetabolites, Antineoplastic
  • Deoxycytidine
  • Capecitabine
  • Thymidine Phosphorylase
  • Fluorouracil
Topics
  • Angiogenesis Inhibitors (pharmacology, therapeutic use)
  • Animals
  • Antimetabolites, Antineoplastic (pharmacology, therapeutic use)
  • Capecitabine
  • Clinical Trials as Topic
  • Deoxycytidine (analogs & derivatives, pharmacology, therapeutic use)
  • Fluorouracil (analogs & derivatives, pharmacology, therapeutic use)
  • Humans
  • Neoplasms (blood supply, drug therapy)
  • Neovascularization, Pathologic (drug therapy)
  • Patents as Topic
  • Radiotherapy (adverse effects)
  • Regional Blood Flow
  • Thymidine Phosphorylase (antagonists & inhibitors, biosynthesis)
  • Up-Regulation (drug effects, radiation effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: